IRS-1/2 activates downstream signaling proteins such as PI3K/AKT/mTOR and Ras/Raf/MAPK, and this role has been documented in all molecular subtypes of breast cancer (Figure 2) [15]. This evidence concerns the gene IRS1 and breast carcinoma.